…Background The pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD) remains unclear, and effective therapeutic strategies are lacki…
MASLD
This disease is selected. Its supporting articles are shown below.
Articles mentioning MASLD
77 articles · page 3 of 7…dwide, quietly expanding alongside the global surge in obesity, diabetes, and sedentary lifestyles. Traditional markers such as body mas…
… (p=0.046).Conclusion Patients without or with cirrhosis due to MASLD treated with resmetirom experience sustained improvement in sel…
…onist. Phase II data show tirzepatide is effective in resolving steatohepatitis in patients with MASLD with fibrosis at 52 weeks.2 However, no …
…Background Metabolic-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease affecting approximately a …
…xhibited comparable HCC risk (HR=1.76; 95% CI 0.84 to 3.71) and extrahepatic cancer risk (HR=1.14; 95% CI 0.88 to 1.48), but reduced CVD risk (HR=0…
…698; PMCID: PMC7614852.Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk f…
… FFMI/BMI z-score).In our cohort of patients with biopsy proven MASLD, none of the patients were sarcopenic per se. HOMA-IR had a sig…
…t al, which, through a large-scale meta-analysis, revealed that hypothyroidism is associated with an elevated risk of metabolic dysfunction-as…